Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
about
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesUse of Cell-Penetrating Peptides in Dendritic Cell-Based VaccinationThe Dectin-2 family of C-type lectin-like receptors: an updateThe known unknowns of the human dendritic cell networkThe antigen presenting cells instruct plasma cell differentiationTrial watch: Dendritic cell-based anticancer therapyDelivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In VivoDendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytesRole of the C-type lectin receptors MCL and DCIR in experimental colitisState-of-the-art of regulatory dendritic cells in cancerDendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitorsImmunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment.Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsMolecular control of steady-state dendritic cell maturation and immune homeostasis.Macrophage- and neutrophil-derived TNF-α instructs skin langerhans cells to prime antiviral immune responsesDesigning vaccines based on biology of human dendritic cell subsetsMurine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.Dendritic-cell-based therapeutic cancer vaccinesC-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses.Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.Optimizing dendritic cell-based approaches for cancer immunotherapyDendritic cell-based vaccines: barriers and opportunitiesInhibitory C-type lectin receptors in myeloid cells.Classification of current anticancer immunotherapiesSkin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses.A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40.Signaling by myeloid C-type lectin receptors in immunity and homeostasisPhenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans CellsRoute of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinomaTargeting Dendritic Cells in vivo for Cancer Therapy.Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation.Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses in vitro and in vivo.Trial watch: Dendritic cell-based interventions for cancer therapyDendritic cells and vaccine design for sexually-transmitted diseases.Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T CellsGenetic variability in the rat Aplec C-type lectin gene cluster regulates lymphocyte trafficking and motor neuron survival after traumatic nerve root injuryTargeting CLEC9A delivers antigen to human CD141(+) DC for CD4(+) and CD8(+)T cell recognitionHIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsGlycobiology of immune responsesDendritic cells, inflammation, and breast cancer.
P2860
Q26752558-4248D658-DFA3-4907-8062-4ACACF53146CQ26764861-6B9288BD-4C9A-4221-BAA2-3691E4B70EB5Q26861638-1EFB1FCA-4F66-488D-9D81-49E74FD15E6CQ26865854-48DAD633-4AEF-4E5A-9B51-29E63FD58471Q26995780-33703CD0-6942-4788-859F-30B4589A07FAQ27024047-9F478F70-FE5F-46A9-B843-A543E213292EQ27300713-C898F583-E122-41E7-A47F-DE4A193E7961Q27310806-0538EC7E-BC0A-45CD-85EC-9CF7F91E2818Q27317611-DCB2603B-391D-4107-ABB8-359F7D9792F1Q28383942-D776F330-24EE-434A-8449-A10EA7B85078Q28534580-471CEE25-A084-4F16-BAAA-0BBB97C75C84Q30367637-286B4B86-5B86-476F-B7F4-73BCADA9547AQ33613138-5BC51F3D-A514-4300-AF49-CE2102BCEACBQ33882051-9F99848B-BF76-48DF-B7C4-8674ED328DD2Q34053805-01267BE8-3139-4F7C-8BE9-043885A87BFCQ34289152-1D907660-B56F-4286-8267-7BA0A2291BC1Q34342500-146B10A7-3B5F-4385-8A8D-639435007188Q34360094-33EA1108-3925-4726-B50D-704D85B4F2E3Q34458766-31C62164-F083-4436-BC52-74DFB3184595Q34481835-80DBCFF5-29B0-42E9-8967-AA5490C3285EQ34637535-9CAE32F6-CF78-4682-8F57-DE76E673C737Q34661797-93E99975-6D21-445C-9F57-C31DEF2DF251Q34700805-818E654A-1299-4B0B-AF88-927DA25FBBD1Q35149637-46235905-D82C-48E4-943F-AA582C026DE2Q35184456-9FDD02C5-29C4-4092-A5EC-8D9AC2B0AD6CQ35584127-E5CCC7EB-B313-4416-9C17-49937586550FQ35779708-55F0BC70-72B4-4B6C-AE45-241478D0C377Q35852261-C560F8F5-FE8C-4ADB-AF33-E06C908F2EF6Q35871590-9240C036-5185-4DA9-A46F-574808947411Q35928270-78F43196-EB97-450B-BD76-D36FC286AA5AQ35928276-33922C59-D688-4561-B586-FDA4DDF9B6CAQ36179478-40E1E8F1-83C7-466E-9047-93385FFCFE03Q36388529-90D4BB5B-F10B-4AD8-97FE-B8155FD42464Q36681262-F1BD08EE-9DB5-4A73-8A44-EA8CA1228090Q36754182-82F26075-CCCE-4DEA-A1D8-86A4D57F91CAQ36866992-B5CD2E2E-3A61-4CF4-A1C9-EDE2C658F0D3Q37277188-AD37C6FB-F9F1-403C-BCFF-EE072CB5D624Q37287774-889BFDB6-2A7A-42E9-B1B7-772555366BD4Q37448685-E31D8F70-2381-4CA0-A307-3175A4C6DD93Q37456825-08B7366B-F229-4FC0-B7E3-FBB420243D3F
P2860
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@ast
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@en
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@nl
type
label
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@ast
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@en
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@nl
prefLabel
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@ast
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@en
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@nl
P2093
P2860
P1433
P1476
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
@en
P2093
A Karolina Palucka
Anne-Laure Flamar
Eynav Klechevsky
Jean-Philippe Blanck
Luann Thompson-Snipes
Maochang Liu
Olivier Agouna-Deciat
Peter Klucar
Sandra Zurawski
P2860
P304
P356
10.1182/BLOOD-2010-01-264960
P407
P577
2010-06-07T00:00:00Z